KRISTEN SELLAND

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner HIAWATHA, KS NPI 1013308295

General Payments — all program years on this page

$1,166.57

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 65
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $418.75 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $418.7522

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $54.343
2022 $329.8020
2023 $363.6820
2024 $418.7522

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087168597 Novartis Pharmaceuticals Corporation $14.30 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087168605 Novartis Pharmaceuticals Corporation $14.54 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087168607 Novartis Pharmaceuticals Corporation $16.31 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100614879 Novo Nordisk Inc $13.88 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104265301 AstraZeneca Pharmaceuticals LP $13.52 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105205208 AstraZeneca Pharmaceuticals LP $13.20 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108172332 ABBVIE INC. $15.44 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108172334 ABBVIE INC. $24.31 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108172336 ABBVIE INC. $18.11 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108172338 ABBVIE INC. $17.63 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117378696 Amgen Inc. $15.27 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117679619 Amgen Inc. $18.06 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117836368 Boehringer Ingelheim Pharmaceuticals, Inc. $20.38 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131520065 PFIZER INC. $14.22 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131545038 PFIZER INC. $18.62 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133969023 Vanda Pharmaceuticals Inc. $29.60 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135761737 Lilly USA, LLC $24.64 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135776662 Lilly USA, LLC $23.80 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135781206 Lilly USA, LLC $26.67 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139767938 GENZYME CORPORATION $32.11 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151204321 Phathom Pharmaceuticals, Inc. $15.82 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153372557 Dexcom, Inc. $18.32 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.